FINWIRES · TerminalLIVE
FINWIRES

$QNCX

3 stories mentioning QNCXUpdated 9d ago

Every FINWIRES story that references QNCX, newest first.

Research

Oppenheimer Initiates Quince Therapeutics at Outperform With $82 Price Target

$QNCX
Research

Leerink Partners Initiates Quince Therapeutics at Outperform With $4 Price Target

$QNCX
Research

Cantor Fitzgerald Initiates Quince Therapeutics at Overweight With $4 Price Target

$QNCX

Track with the FINWIRES app suite

FolioX
FolioX
Track QNCX in your portfolio
WheelAI
WheelAI
Analyze QNCX options with the wheel strategy
StockInsider
StockInsider
See market sentiment on QNCX